Higher Rebates for Brand-Name Drugs Result in Lower Costs for Medicaid Compared to Medicare Part D

United States Government Publishing Office publisher pbl distributor dst United States Health and Human Services Department author aut Government Organization text government publication eng GOVPUB Executive Agency Publications executive 2023-08-31 Health and Human Services Department 2011-01-01 monographic harvested born digital 29 digital object pages HE 1.75:OEI-03-10-00320 https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo68404 P0b002ee1c04528b6 000985832 https://purl.fdlp.gov/GPO/gpo68404 (OCoLC)952178269 DGPO 2023-08-31 2026-06-28 GOVPUB-HE-PURL-gpo68404 machine generated eng fdlp HE GOVPUB-HE-PURL-gpo68404 PURL-gpo68404 GOVPUB This content was harvested from online sources of the original hosting or authoring agency and may not reflect current policy. As Federal agencies add publications to their websites, or report new publications to GPO per statutory mandate (44 U.S.C. §§ 1710, 1902-1903), GPO ensures long-term preservation of and access to the content. 2011 PERM_INGEST_04282022 gpo68404 https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo68404 https://www.govinfo.gov/content/pkg/GOVPUB-HE-PURL-gpo68404/pdf/GOVPUB-HE-PURL-gpo68404.pdf Higher Rebates for Brand-Name Drugs Result in Lower Costs for Medicaid Compared to Medicare Part D Auditing Brand name products Drugs Medicaid Medicare Pharmaceutical services insurance Prices United States 0445-B-07 (online) United States Department of Health and Human Services. Office of Inspector General, creator author. dcu Department of Health and Human Services, Office of Inspector General 2011. monographic 1 online resource (iv, 22 pages) : color illustrations HE 1.75:OEI-03-10-00320 0445-B-07 (online) text bibliography eng Title from title screen (viewed June 23, 2016). "August 2011." "OEI-03-10-00320." Includes bibliographical references. n-us--- Medicare Medicaid Pharmaceutical services insurance United States Auditing Drugs Prices United States Brand name products Prices United States https://purl.fdlp.gov/GPO/gpo68404 http://oig.hhs.gov/oei/reports/oei-03-10-00320.pdf https://catalog.gpo.gov/fdlpdir/locate.jsp?ItemNumber=0445-B-07&SYS=000985832 Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D